# GORE® EXCLUDER® Endoprosthesis French Mandatory Registry

> **NCT02308839** · — · COMPLETED · sponsor: **W.L.Gore & Associates** · enrollment: 181 (actual)

## Conditions studied

- Abdominal Aortic Aneurysm

## Interventions

- **DEVICE:** GORE® EXCLUDER® Endoprosthesis

## Key facts

- **NCT ID:** NCT02308839
- **Lead sponsor:** W.L.Gore & Associates
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2018-09-26
- **Final completion:** 2018-10-05
- **Target enrollment:** 181 (ACTUAL)
- **Last updated:** 2020-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02308839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02308839, "GORE® EXCLUDER® Endoprosthesis French Mandatory Registry". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT02308839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*